278 related articles for article (PubMed ID: 22638551)
21. Expression of MAGE-A cancer/testis antigens in esophageal squamous cell carcinomas.
Haier J; Owzcareck M; Guller U; Spagnoli GC; Bürger H; Senninger N; Kocher T
Anticancer Res; 2006; 26(3B):2281-7. PubMed ID: 16821603
[TBL] [Abstract][Full Text] [Related]
22. Detection of circulating lymphoma cells in patients with non-Hodgkin lymphoma using MAGE-A3 gene expression in peripheral blood.
Han MH; Eom HS; Park WS; Yun T; Park S; Kim HJ; Jeon CH; Kong SY
Leuk Res; 2010 Sep; 34(9):1127-31. PubMed ID: 20036422
[TBL] [Abstract][Full Text] [Related]
23. MAGE-A and NY-ESO-1 expression in cervical cancer: prognostic factors and effects of chemotherapy.
Napoletano C; Bellati F; Tarquini E; Tomao F; Taurino F; Spagnoli G; Rughetti A; Muzii L; Nuti M; Benedetti Panici P
Am J Obstet Gynecol; 2008 Jan; 198(1):99.e1-7. PubMed ID: 18166319
[TBL] [Abstract][Full Text] [Related]
24. [Expression of multiple cancer-testis antigen genes in non-small cell lung cancer treated by chemotherapy prior surgery].
Wang Y; Liang Z; Yuan YH; Han Y; Liu YX; Liu N; Chen YT; Ritter G; Old LJ; Zhang LJ
Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):464-8. PubMed ID: 15061963
[TBL] [Abstract][Full Text] [Related]
25. Sperm-associated antigens as targets for cancer immunotherapy: expression pattern and humoral immune response in cancer patients.
Siliņa K; Zayakin P; Kalniņa Z; Ivanova L; Meistere I; Endzeliņš E; Abols A; Stengrēvics A; Leja M; Ducena K; Kozirovskis V; Linē A
J Immunother; 2011 Jan; 34(1):28-44. PubMed ID: 21150711
[TBL] [Abstract][Full Text] [Related]
26. Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications.
Balafoutas D; zur Hausen A; Mayer S; Hirschfeld M; Jaeger M; Denschlag D; Gitsch G; Jungbluth A; Stickeler E
BMC Cancer; 2013 Jun; 13():271. PubMed ID: 23731661
[TBL] [Abstract][Full Text] [Related]
27. NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.
Odunsi K; Jungbluth AA; Stockert E; Qian F; Gnjatic S; Tammela J; Intengan M; Beck A; Keitz B; Santiago D; Williamson B; Scanlan MJ; Ritter G; Chen YT; Driscoll D; Sood A; Lele S; Old LJ
Cancer Res; 2003 Sep; 63(18):6076-83. PubMed ID: 14522938
[TBL] [Abstract][Full Text] [Related]
28. Localized B-cell non-Hodgkin's lymphoma of oral cavity and maxillofacial region: a clinical study.
Kolokotronis A; Konstantinou N; Christakis I; Papadimitriou P; Matiakis A; Zaraboukas T; Antoniades D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):303-10. PubMed ID: 15716836
[TBL] [Abstract][Full Text] [Related]
29. Identification of NY-ESO-1, MAGE-1, and MAGE-3 in head and neck squamous cell carcinoma.
Kienstra MA; Neel HB; Strome SE; Roche P
Head Neck; 2003 Jun; 25(6):457-63. PubMed ID: 12784237
[TBL] [Abstract][Full Text] [Related]
30. Cancer-testis antigen expression and immunogenicity in AL amyloidosis.
Rosenzweig MA; Landau H; Seldin D; O'Hara C; Girnius S; Hanson N; Frosina D; Sedrak C; Arcila M; Comenzo RL; Giralt S; Gnjatic S; Jungbluth AA; Koehne G
Blood Cancer J; 2012 Sep; 2(9):e90. PubMed ID: 22983433
[TBL] [Abstract][Full Text] [Related]
31. Detection of autoantibodies against cancer-testis antigens in non-small cell lung cancer.
Djureinovic D; Dodig-Crnković T; Hellström C; Holgersson G; Bergqvist M; Mattsson JSM; Pontén F; Ståhle E; Schwenk JM; Micke P
Lung Cancer; 2018 Nov; 125():157-163. PubMed ID: 30429015
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical analysis of the expression of MAGE-A and NY-ESO-1 cancer/testis antigens in diffuse large B-cell testicular lymphoma.
Hudolin T; Kastelan Z; Ilic I; Levarda-Hudolin K; Basic-Jukic N; Rieken M; Spagnoli GC; Juretic A; Mengus C
J Transl Med; 2013 May; 11():123. PubMed ID: 23680437
[TBL] [Abstract][Full Text] [Related]
33. Expression and immune responses to MAGE antigens predict survival in epithelial ovarian cancer.
Daudi S; Eng KH; Mhawech-Fauceglia P; Morrison C; Miliotto A; Beck A; Matsuzaki J; Tsuji T; Groman A; Gnjatic S; Spagnoli G; Lele S; Odunsi K
PLoS One; 2014; 9(8):e104099. PubMed ID: 25101620
[TBL] [Abstract][Full Text] [Related]
34. Expression of cancer-testis antigens in endometrial carcinomas using a tissue microarray.
Chitale DA; Jungbluth AA; Marshall DS; Leitao MM; Hedvat CV; Kolb D; Spagnoli GC; Iversen K; Soslow RA
Mod Pathol; 2005 Jan; 18(1):119-26. PubMed ID: 15272278
[TBL] [Abstract][Full Text] [Related]
35. Combined cancer testis antigens enhanced prediction accuracy for prognosis of patients with hepatocellular carcinoma.
Wang M; Li J; Wang L; Chen X; Zhang Z; Yue D; Ping Y; Shi X; Huang L; Zhang T; Yang L; Zhao Y; Ma X; Li D; Fan Z; Zhao L; Tang Z; Zhai W; Zhang B; Zhang Y
Int J Clin Exp Pathol; 2015; 8(4):3513-28. PubMed ID: 26097535
[TBL] [Abstract][Full Text] [Related]
36. NY-ESO-1 protein expression and humoral immune responses in prostate cancer.
Fosså A; Berner A; Fosså SD; Hernes E; Gaudernack G; Smeland EB
Prostate; 2004 Jun; 59(4):440-7. PubMed ID: 15065093
[TBL] [Abstract][Full Text] [Related]
37. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
Thomas R; Al-Khadairi G; Roelands J; Hendrickx W; Dermime S; Bedognetti D; Decock J
Front Immunol; 2018; 9():947. PubMed ID: 29770138
[TBL] [Abstract][Full Text] [Related]
38. Cancer/testis antigen expression and autologous humoral immunity to NY-ESO-1 in gastric cancer.
Wang Y; Wu XJ; Zhao AL; Yuan YH; Chen YT; Jungbluth AA; Gnjatic S; Santiago D; Ritter G; Chen WF; Old LJ; Ji JF
Cancer Immun; 2004 Nov; 4():11. PubMed ID: 15516106
[TBL] [Abstract][Full Text] [Related]
39. Melanoma: a prototype of cancer-testis antigen-expressing malignancies.
Faramarzi S; Ghafouri-Fard S
Immunotherapy; 2017 Oct; 9(13):1103-1113. PubMed ID: 29032737
[TBL] [Abstract][Full Text] [Related]
40. Cancer-testis antigens: promising targets for antigen directed antineoplastic immunotherapy.
Bodey B
Expert Opin Biol Ther; 2002 Aug; 2(6):577-84. PubMed ID: 12171503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
